دورية أكاديمية
أعرض في EDS

Heated tobacco product marketing: a mixed-methods study examining exposure and perceptions among US and Israeli adults.

التفاصيل البيبلوغرافية
العنوان: Heated tobacco product marketing: a mixed-methods study examining exposure and perceptions among US and Israeli adults.
المؤلفون: Cui Y; Department of Prevention and Community Health, Milken Institute School of Public Health, George Washington University, 950 New Hampshire Avenue, Washington, DC 20052, USA., Bar-Zeev Y; Braun School of Public Health and Community Medicine, Faculty of Medicine, The Hebrew University of Jerusalem and Hadassah Medical Center, 7 Ramat Gan, Jerusalem, 9112102, Israel., Levine H; Braun School of Public Health and Community Medicine, Faculty of Medicine, The Hebrew University of Jerusalem and Hadassah Medical Center, 7 Ramat Gan, Jerusalem, 9112102, Israel., LoParco CR; Department of Prevention and Community Health, Milken Institute School of Public Health, George Washington University, 950 New Hampshire Avenue, Washington, DC 20052, USA., Duan Z; School of Public Health, Georgia State University, 140 Decatur St. SE, Atlanta, GA 30303, USA., Wang Y; GW Cancer Center, George Washington University, 800 22nd Street NW, Washington, DC 20052, USA., Abroms LC; GW Cancer Center, George Washington University, 800 22nd Street NW, Washington, DC 20052, USA., Khayat A; Braun School of Public Health and Community Medicine, Faculty of Medicine, The Hebrew University of Jerusalem and Hadassah Medical Center, 7 Ramat Gan, Jerusalem, 9112102, Israel., Berg CJ; GW Cancer Center, George Washington University, 800 22nd Street NW, Washington, DC 20052, USA.
المصدر: Health education research [Health Educ Res] 2024 Jul 18; Vol. 39 (4), pp. 375-397.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural
اللغة: English
بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 8608459 Publication Model: Print Cited Medium: Internet ISSN: 1465-3648 (Electronic) Linking ISSN: 02681153 NLM ISO Abbreviation: Health Educ Res Subsets: MEDLINE
أسماء مطبوعة: Publication: Oxford : Oxford University Press
Original Publication: Oxford ; Washington, D.C. : IRL Press, [c1986-
مواضيع طبية MeSH: Tobacco Products* , Marketing*/methods, Humans ; Israel ; Female ; Male ; Adult ; Middle Aged ; United States ; Electronic Nicotine Delivery Systems ; Surveys and Questionnaires ; Young Adult ; Adolescent ; Perception
مستخلص: The marketing of heated tobacco products (HTPs), like IQOS, influences consumers' perceptions. This mixed-methods study analyzed (i) survey data (2021) of 2222 US and Israeli adults comparing perceptions of 7 IQOS attributes (design, technology, colors, customization, flavors, cost and maintenance) and 10 marketing messages (e.g. 'Go smoke-free…') across tobacco use subgroups and (ii) qualitative interviews (n = 84) regarding IQOS perceptions. In initial bivariate analyses, those never using HTPs (86.2%) reported the least overall appeal; those currently using HTPs (7.7%) reported the greatest appeal. Notably, almost all (94.8%) currently using HTPs also currently used cigarettes (82.0%) and/or e-cigarettes (64.0%). Thus, multivariable linear regression accounted for current cigarette/e-cigarette use subgroup and HTP use separately; compared to neither cigarette/e-cigarette use (62.8%), cigarette/no e-cigarette use (17.1%) and e-cigarette/no cigarette use (6.5%), those with dual use (13.5%) indicated greater overall IQOS appeal (per composite index score); current HTP use was not associated. Qualitative data indicated varied perceptions regarding advantages (e.g. harm, addiction and complexity) of IQOS versus cigarettes and e-cigarettes, and perceived target markets included young people, those looking for cigarette alternatives and females. Given the perceived target markets and particular appeal to dual cigarette/e-cigarette use groups, IQOS marketing and population impact warrant ongoing monitoring to inform regulation.
(© The Author(s) 2024. Published by Oxford University Press. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site–for further information please contact journals.permissions@oup.com.)
References: J Epidemiol. 2022 Mar 5;32(3):139-144. (PMID: 33456019)
Tob Control. 2023 Aug;32(e2):e198-e204. (PMID: 35140170)
Nicotine Tob Res. 2022 Jan 1;24(1):100-108. (PMID: 34216461)
Nicotine Tob Res. 2022 Nov 12;24(12):1968-1977. (PMID: 35901840)
Tob Control. 2024 Mar 19;33(e1):e3-e10. (PMID: 36368887)
Int J Environ Res Public Health. 2023 Feb 10;20(4):. (PMID: 36833831)
Tob Control. 2017 May;26(3):307-315. (PMID: 27255118)
Tob Control. 2018 Nov;27(Suppl 1):s87-s95. (PMID: 30209208)
Tob Control. 2012 Mar;21(2):147-53. (PMID: 22345238)
Health Serv Res. 2013 Dec;48(6 Pt 2):2134-56. (PMID: 24279835)
MMWR Morb Mortal Wkly Rep. 2023 May 05;72(18):475-483. (PMID: 37141154)
Tob Control. 2018 Nov;27(Suppl 1):s74-s77. (PMID: 30158210)
Tob Control. 2018 Nov;27(Suppl 1):s62-s69. (PMID: 30158212)
Tob Control. 2024 Mar 19;33(e1):e69-e77. (PMID: 36428095)
Tob Control. 2020 Dec;29(e1):e152-e154. (PMID: 32024772)
Drug Alcohol Depend. 2021 Dec 1;229(Pt B):109136. (PMID: 34763136)
NPJ Prim Care Respir Med. 2023 Mar 2;33(1):8. (PMID: 36864067)
Tob Control. 2020 Dec;29(e1):e18-e24. (PMID: 32029537)
Addiction. 2016 Apr;111(4):706-13. (PMID: 26566956)
Int J Environ Res Public Health. 2022 Nov 08;19(22):. (PMID: 36429359)
Tob Control. 2016 Sep;26(5):609-610. (PMID: 27558827)
Tob Control. 2019 Mar;28(2):237-238. (PMID: 29724866)
Tob Control. 2018 Nov;27(Suppl 1):s55-s61. (PMID: 30158204)
Int J Environ Res Public Health. 2021 Jun 21;18(12):. (PMID: 34205612)
Tob Control. 2022 Aug;31(e1):e41-e49. (PMID: 33688084)
Tob Control. 2019 Jan;28(1):113-114. (PMID: 29374094)
Prev Med Rep. 2023 Apr 15;33:102209. (PMID: 37223575)
Tob Control. 2024 Jun 20;33(4):518-524. (PMID: 36927516)
Tob Control. 2023 Jan;32(1):42-50. (PMID: 34059552)
Nicotine Tob Res. 2023 Sep 4;25(11):1798-1803. (PMID: 37338204)
Tob Control. 2015 Jul;24(4):410-2. (PMID: 24727649)
Nicotine Tob Res. 2022 Mar 1;24(4):493-502. (PMID: 34669964)
Nicotine Tob Res. 2021 Oct 7;23(11):1967-1971. (PMID: 33822111)
Isr J Health Policy Res. 2019 May 27;8(1):47. (PMID: 31133053)
Am J Prev Med. 2011 Jun;40(6):683-9. (PMID: 21565662)
Tob Control. 2024 Mar 19;33(e1):e54-e61. (PMID: 36418166)
Tob Control. 2020 Jan;29(1):89-95. (PMID: 30696783)
Tob Control. 2021 Nov;30(e1):e62-e64. (PMID: 32887740)
Am J Prev Med. 2011 Jun;40(6):674-82. (PMID: 21565661)
Sage Open. 2020 Jan-Mar;10(1):. (PMID: 32719733)
Health Educ Res. 2022 Sep 23;37(5):364-377. (PMID: 36036655)
Tob Control. 2011 May;20 Suppl 2:ii20-8. (PMID: 21504928)
Tob Control. 2023 Jul;32(4):418-427. (PMID: 34667105)
Tob Control. 2019 Jan;28(1):67-73. (PMID: 29622602)
Int J Environ Res Public Health. 2021 Oct 08;18(19):. (PMID: 34639851)
Harm Reduct J. 2021 Apr 13;18(1):42. (PMID: 33849549)
Tob Control. 2023 Aug;32(e2):e260-e264. (PMID: 35918133)
Tob Control. 2018 Nov;27(Suppl 1):s70-s73. (PMID: 29764957)
معلومات مُعتمدة: R01 CA239178 United States CA NCI NIH HHS; R01CA239178 Division of Cancer Prevention, National Cancer Institute; R01 CA215155 United States CA NCI NIH HHS; R01 CA278229 United States CA NCI NIH HHS; R01 CA275066 United States CA NCI NIH HHS; R01 TW010664 United States TW FIC NIH HHS; D43 TW012456 United States TW FIC NIH HHS; D43 ES030927 United States ES NIEHS NIH HHS; R01 DA054751 United States DA NIDA NIH HHS
تواريخ الأحداث: Date Created: 20240513 Date Completed: 20240719 Latest Revision: 20240912
رمز التحديث: 20240912
مُعرف محوري في PubMed: PMC11258801
DOI: 10.1093/her/cyae018
PMID: 38739472
قاعدة البيانات: MEDLINE
الوصف
تدمد:1465-3648
DOI:10.1093/her/cyae018